Adding preoperative radiotherapy plus cetuximab to perioperative chemotherapy for resectable esophageal adenocarcinoma: a single-center prospective phase II trial

I. Ubink; P.C. van der Sluis; M.E.I. Schipper; O. Reerink; E.E. Voest; I.H.M. Borel Rinkes; H.K. Wijrdeman; F.P. Vleggaar; M.J. Agterof; E.N.M. Overkleeft; P.D. Siersema; R. van Hillegersberg; M.P.J.K. Lolkema

Adding preoperative radiotherapy plus cetuximab to perioperative chemotherapy for resectable esophageal adenocarcinoma: a single-center prospective phase II trial

I. Ubink
, P.C. van der Sluis
, M.E.I. Schipper
, O. Reerink
, E.E. Voest
, I.H.M. Borel Rinkes
, H.K. Wijrdeman
, F.P. Vleggaar
, M.J. Agterof
, E.N.M. Overkleeft
, P.D. Siersema
, R. van Hillegersberg
, M.P.J.K. Lolkema

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	32-33
Number of pages	2
Journal	Oncologist
Volume	19
Issue number	1
Publication status	Published - 2014

Access to Document

http://www.ncbi.nlm.nih.gov/pubmed/24335595

Cite this

Ubink, I., van der Sluis, P. C., Schipper, M. E. I., Reerink, O., Voest, E. E., Borel Rinkes, I. H. M., Wijrdeman, H. K., Vleggaar, F. P., Agterof, M. J., Overkleeft, E. N. M., Siersema, P. D., van Hillegersberg, R., & Lolkema, M. P. J. K. (2014). Adding preoperative radiotherapy plus cetuximab to perioperative chemotherapy for resectable esophageal adenocarcinoma: a single-center prospective phase II trial. Oncologist, 19(1), 32-33. http://www.ncbi.nlm.nih.gov/pubmed/24335595

@article{f79c8729b10840aa8ba987c0f32862ca,

title = "Adding preoperative radiotherapy plus cetuximab to perioperative chemotherapy for resectable esophageal adenocarcinoma: a single-center prospective phase II trial",

author = "I. Ubink and \{van der Sluis\}, P.C. and M.E.I. Schipper and O. Reerink and E.E. Voest and \{Borel Rinkes\}, I.H.M. and H.K. Wijrdeman and F.P. Vleggaar and M.J. Agterof and E.N.M. Overkleeft and P.D. Siersema and \{van Hillegersberg\}, R. and M.P.J.K. Lolkema",

year = "2014",

language = "English",

volume = "19",

pages = "32--33",

journal = "Oncologist",

issn = "1083-7159",

publisher = "Oxford University Press",

number = "1",

}

Ubink, I, van der Sluis, PC, Schipper, MEI, Reerink, O, Voest, EE , Borel Rinkes, IHM, Wijrdeman, HK, Vleggaar, FP, Agterof, MJ, Overkleeft, ENM, Siersema, PD, van Hillegersberg, R & Lolkema, MPJK 2014, 'Adding preoperative radiotherapy plus cetuximab to perioperative chemotherapy for resectable esophageal adenocarcinoma: a single-center prospective phase II trial', Oncologist, vol. 19, no. 1, pp. 32-33. <http://www.ncbi.nlm.nih.gov/pubmed/24335595>

TY - JOUR

T1 - Adding preoperative radiotherapy plus cetuximab to perioperative chemotherapy for resectable esophageal adenocarcinoma: a single-center prospective phase II trial

AU - Ubink, I.

AU - van der Sluis, P.C.

AU - Schipper, M.E.I.

AU - Reerink, O.

AU - Voest, E.E.

AU - Borel Rinkes, I.H.M.

AU - Wijrdeman, H.K.

AU - Vleggaar, F.P.

AU - Agterof, M.J.

AU - Overkleeft, E.N.M.

AU - Siersema, P.D.

AU - van Hillegersberg, R.

AU - Lolkema, M.P.J.K.

PY - 2014

Y1 - 2014

M3 - Article

SN - 1083-7159

VL - 19

SP - 32

EP - 33

JO - Oncologist

JF - Oncologist

IS - 1

ER -